ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2014

Abstract Number: 1204

Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NFkB Signaling and Macrophage Migration

Nicholas A. Young1, Michael Bruss2, Mark Gardner3, William Willis3, Xiaokui Mo3, Giancarlo Valiente3, Yu Cao4, Zhongfa Liu4, Lai-Chu Wu1 and Wael N. Jarjour5, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Rheumatology and Immunology, The Ohio State University Wexner Medical Center, columbus, OH, 5Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: Imaging, Inflammation, Macrophage migration inhibitory factor (MIF), nanomedicine and transcriptional regulation

Session Information

Title: Innate Immunity and Rheumatic Disease: Signaling Mechanisms

Session Type: Abstract Submissions (ACR)

Background/Purpose: The major obstacles to successful use of curcumin as an anti-inflammatory agent are its low solubility in water and rapid metabolism, which both translate to poor systemic bioavailability.  To protect against metabolism and to enhance accessibility systemically, we have previously reported a novel formulation of nano-emulsified curcumin (NEC) that increases relative bioavailability by over 10-fold.  In this study, we validated the bioactivity of NEC in vivo and characterized the associated mechanisms of immunosuppression.

Methods: Since curcumin has been shown to inhibit NFkB activation, we used BALB/C-Tg(NFkB-RE-luc)-Xen mice, which contain a firefly luciferase reporter gene under the control of kB responsive elements.  Mice were treated with identical concentrations of curcumin in aqueous suspension (SC) or NEC by oral gavage and subsequently challenged with LPS.  Acute systemic inflammation was measured and quantitated on the Xenogen in vivo imaging system (IVIS 200).  Whole blood was collected for flow cytometry and serum was analyzed by ELISA.  Acute peritonitis was induced in BALB/C mice by thioglycollate injection with and without NEC administration by oral gavage; peritoneal lavages were isolated for flow cytometry.  Scratch assays to measure cell migration were performed on a human cells.

Results:   Treatment with NEC significantly reduced LPS-induced inflammation relative to SC, as measured by IVIS detection of NFkB activity.  Flow cytometry of peripheral blood indicated that circulating monocytes were reduced with administration of NEC and levels of LPS receptors TLR4 and RAGE were down-regulated on the surface of cells.  Induction of monocyte chemoattractant protein (MCP)-1 secretion by LPS stimulation was significantly reduced with NEC administration.  While macrophage recruitment was significantly reduced with NEC administration in thioglycollate-induced peritonitis, levels of T-cells and B-cells were not affected.  Scratch assays to measure in vitro cell migration showed that curcumin significantly inhibited responses in both THP-1 cells and primary human macrophages.      

Conclusion:   In this study, we establish a novel system to screen and validate curcumin-derived drugs for longitudinal analysis in vivo.  Furthermore, our results validate NEC as a candidate for future therapeutic studies and demonstrate that curcumin can suppress inflammation by selectively inhibiting macrophage migration via NFkB and MCP-1 inhibition. 

 

 


Disclosure:

N. A. Young,
None;

M. Bruss,
None;

M. Gardner,
None;

W. Willis,
None;

X. Mo,
None;

G. Valiente,
None;

Y. Cao,
None;

Z. Liu,
None;

L. C. Wu,
None;

W. N. Jarjour,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/oral-administration-of-nano-emulsion-curcumin-in-mice-suppresses-inflammatory-induced-nfkb-signaling-and-macrophage-migration/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology